← back to search

Jörn C. Albring

University Hospital Münster ·
Area of research
Immunology · Hematology
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, and Immune Cell Function and Interaction.
h-index
18
citations
3,651
works
47
NIH funding
primary concept
email

Recent publications

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
The Lancet Haematology 2024cited by 49position: middledoi
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study
Journal of Clinical Oncology 2023cited by 51position: middledoi
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 12position: middledoi
<i>Mafb</i> lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells
The Journal of Experimental Medicine 2016cited by 122position: middledoi
RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells
The Journal of Experimental Medicine 2016cited by 73position: middledoi
L-Myc expression by dendritic cells is required for optimal T-cell priming
Nature 2014cited by 79position: middledoi
<i>Zbtb46</i> expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
The Journal of Experimental Medicine 2012cited by 608position: middledoi
Re(de)fining the dendritic cell lineage
Nature Immunology 2012cited by 423position: middledoi
Compensatory dendritic cell development mediated by BATF–IRF interactions
Nature 2012cited by 411position: middledoi
Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation
Blood 2012cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kenneth M. Murphy · Saint Louis University7 papers (2012–2016)Theresa L. Murphy · Washington University in St. Louis6 papers (2012–2016)Xiaodi Wu · Memorial Sloan Kettering Cancer Center5 papers (2012–2016)Ansuman T. Satpathy · Stanford University5 papers (2012–2014)Wumesh KC · Translational Therapeutics (United States)4 papers (2012–2014)Nicole M. Kretzer · St. Joseph Health System4 papers (2012–2016)Carlos G. Briseño · Washington University in St. Louis3 papers (2014–2016)Vivek Durai · Washington University in St. Louis3 papers (2014–2016)Brian T. Edelson · Washington University in St. Louis3 papers (2012–2014)Prachi Bagadia · FibroGen (United States)2 papers (2016–2016)Roxane Tussiwand · National Institute of Dental and Craniofacial Research2 papers (2012–2016)Ki-wook Kim · Regenerative Medicine Institute1 papers (2016–2016) · 1 papers (2012–2012) · 1 papers (2012–2012)Ahmad Mokatrin · AbbVie (United States)1 papers (2023–2023) · 1 papers (2012–2012)Bor‐Sheng Ko · National Taiwan University1 papers (2023–2023)Mona Mashayekhi · Vanderbilt University1 papers (2012–2012)David B. Miklos · Stanford University1 papers (2023–2023)Robert D. Schreiber · Barnes-Jewish Hospital1 papers (2012–2012)